{"url_path":"/sec/ppcb/10-q/2026/item-3","section_key":"item-3","section_title":"Item 3 Defaults Upon Senior Securities.**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1517681/0001493152-26-023210-index.html","accession_number":"0001493152-26-023210","cik":"0001517681","ticker":"PPCB","issuer_name":"Propanc Biopharma, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1517681/0001493152-26-023210-index.html","primary_entity_key":"0001517681","primary_entity_name":"Propanc Biopharma, Inc."},"word_count":74,"has_tables":true,"body_markdown":"**Item\n3. Defaults Upon Senior Securities.**\n\n \n\nAs\nof March 31, 2026, we were in default under certain loans to related parties amounting $211,545 and accrued interest of $50,213, as of\nMarch 31, 2026, subsequent to their maturity date. We are currently in discussions with such lender to extend such maturity date. See\n“Note 5 and 6” to our unaudited condensed consolidated financial statements in Part I of this Quarterly Report for additional\ninformation.\n\n \n\n9"}